These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 11478737)
1. Differential protection and recovery of 5-HT1A receptors from N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) inactivation in regions of rat brain. Vinod KY; Subhash MN; Srinivas BN Neurochem Res; 2001 Feb; 26(2):113-20. PubMed ID: 11478737 [TBL] [Abstract][Full Text] [Related]
2. Regional heterogeneity of serotonin(1A) receptor inactivation and turnover in the aging female rat brain following EEDQ. Keck BJ; Lakoski JM Neuropharmacology; 2000 Apr; 39(7):1237-46. PubMed ID: 10760365 [TBL] [Abstract][Full Text] [Related]
3. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline studies on the role of 5-HT1A and 5-HT2 receptors in mediating foot-shock-induced ultrasonic vocalisation in adult rats. Sánchez C; Mørk A Eur Neuropsychopharmacol; 1999 Jun; 9(4):287-94. PubMed ID: 10422888 [TBL] [Abstract][Full Text] [Related]
4. Facilitation by 8-OH-DPAT of passive avoidance performance in rats after inactivation of 5-HT(1A) receptors. Otano A; García-Osta A; Ballaz S; Frechilla D; Del Río J Br J Pharmacol; 1999 Dec; 128(8):1691-8. PubMed ID: 10588924 [TBL] [Abstract][Full Text] [Related]
5. Inactivation of 5-HT(1A) receptors in hippocampal and cortical homogenates. Alper RH; Nelson DL Eur J Pharmacol; 2000 Feb; 390(1-2):67-73. PubMed ID: 10708708 [TBL] [Abstract][Full Text] [Related]
6. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes. Yocca FD; Iben L; Meller E Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034 [TBL] [Abstract][Full Text] [Related]
7. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) administration for studies of 5-HT1A receptor binding site inactivation and turnover. Keck BJ; Lakoski JM Brain Res Brain Res Protoc; 1997 Oct; 1(4):364-70. PubMed ID: 9384817 [TBL] [Abstract][Full Text] [Related]
8. In vivo estimates of efficacy at 5-HT1A receptors: effects of EEDQ on the ability of agonists to produce lower-lip retraction in rats. Koek W; Assié MB; Zernig G; France CP Psychopharmacology (Berl); 2000 May; 149(4):377-87. PubMed ID: 10867965 [TBL] [Abstract][Full Text] [Related]
9. Inactivation of 5-HT1A and [3H]5-HT binding sites by N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ) in rat brain. Subhash MN; Srinivas BN; Vinod KY; Jagadeesh S Neurochem Res; 1998 Oct; 23(10):1321-6. PubMed ID: 9804289 [TBL] [Abstract][Full Text] [Related]
10. In vivo EEDQ dose-dependently inactivates rat brain 5-HT receptors but not 5-HT uptake sites. Pinto W; Battaglia G Neuroreport; 1993 Oct; 5(1):61-4. PubMed ID: 8280861 [TBL] [Abstract][Full Text] [Related]
11. Time-course of recovery of 5-HT1A receptors and changes in 5-HT1A receptor mRNA after irreversible inactivation with EEDQ. Raghupathi RK; Brousseau DA; McGonigle P Brain Res Mol Brain Res; 1996 Jun; 38(2):233-42. PubMed ID: 8793111 [TBL] [Abstract][Full Text] [Related]
12. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists. Meller E; Goldstein M; Bohmaker K Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223 [TBL] [Abstract][Full Text] [Related]
13. Differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on various 5-HT receptor binding sites in the rat brain. Gozlan H; Laporte AM; Thibault S; Schechter LE; Bolaños F; Hamon M Neuropharmacology; 1994; 33(3-4):423-31. PubMed ID: 7984280 [TBL] [Abstract][Full Text] [Related]
14. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes. Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779 [TBL] [Abstract][Full Text] [Related]
15. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency. Meller E; Li H; Carr KD; Hiller JM J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306 [TBL] [Abstract][Full Text] [Related]
16. Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists. Newman-Tancredi A; Verrièle L; Chaput C; Millan MJ Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):205-17. PubMed ID: 9550290 [TBL] [Abstract][Full Text] [Related]
17. Region-specific serotonin1A receptor turnover following irreversible blockade with EEDQ. Keck BJ; Lakoski JM Neuroreport; 1996 Nov; 7(15-17):2717-21. PubMed ID: 8981454 [TBL] [Abstract][Full Text] [Related]
18. Electrophysiological evidence for a large receptor reserve for inhibition of dorsal raphe neuronal firing by 5-HT1A agonists. Cox RF; Meller E; Waszczak BL Synapse; 1993 Aug; 14(4):297-304. PubMed ID: 8248853 [TBL] [Abstract][Full Text] [Related]
19. Differential receptor reserve for 5-HT1A receptor-mediated regulation of plasma neuroendocrine hormones. Meller E; Bohmaker K J Pharmacol Exp Ther; 1994 Dec; 271(3):1246-52. PubMed ID: 7996433 [TBL] [Abstract][Full Text] [Related]
20. Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain. Casanovas JM; Vilaró MT; Mengod G; Artigas F J Neurochem; 1999 Jan; 72(1):262-72. PubMed ID: 9886078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]